Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof

A technology for hemagglutinin and influenza, applied to medical preparations containing active ingredients, antibody medical ingredients, viruses/bacteriophages, etc., can solve the problem of limited ability to induce protective neutralizing antibody titers, and is unlikely to significantly improve protection Issues such as potency and breadth of sexual immunity

Pending Publication Date: 2019-08-23
UNITED STATES OF AMERICA
View PDF19 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

On the contrary, due to the nature of their assembly, enveloped VLPs contain small and limited host cell components, which may pose potential safety, immunogenicity challenges after repeated use of the platform [Wu, C.Y. et al., PLoS One 5, e9784 (2010)]
Also, VLPs induce the same immunity as existing vaccines, and are therefore unlikely to significantly improve the potency and breadth of vaccine-induced protective immunity
In addition to VLPs, recombinant HA proteins have also been evaluated in humans [Treanor, J.J. et al., Vaccine 19, 1732-1737 (2001); Treanor, J.J. JAMA 297, 1577-1582 (2007)], but their induction of protection was modest. and antibody titer capabilities are limited

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof
  • Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof
  • Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0268] This example characterizes the properties and activities of five Group 2 HA nanoparticle H10 variants designed using the parameters and methods disclosed in this application. All these variants are based on the human A / Jiangxi / IPB13 / 2013 (H10N8) strain. A nucleic acid molecule encoding an H10 variant is introduced into Expi293 cells, and the cells are cultured under conditions suitable for expression of the encoded variant protein. Expressed nanoparticles were purified from cell culture supernatants using lectin affinity chromatography followed by size exclusion chromatography (SEC). Chromatograms of purified nanoparticles as Figures 32A-32E shown.

[0269] The purified nanoparticles were analyzed using negative-stain electron microscopy, which revealed the formation of individual nanoparticles with HA stems protruding outwards in a periodic arrangement. Representative SEM images of each variant are shown in Figure 33.

[0270] The antigenicity of H10ssF variants w...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

Vaccines that elicit broadly protective anti-influenza antibodies. The vaccines comprise nanoparticles that display HA trimers from Group 2 influenza virus on their surface. The nanoparticles are fusion proteins comprising a monomeric subunit (e.g., ferritin) joined to stabilized stem regions of Group 2 influenza virus HA proteins. The fusion proteins self-assemble to form the HA-displaying nanoparticles. Also provided are fusion proteins, and nucleic acid molecules encoding such proteins, and assays using nanoparticles of the invention to detect anti-influenza antibodies.

Description

Background technique [0001] The protective immune response induced by vaccination against influenza virus is mainly directed against the viral HA protein, a glycoprotein on the viral surface responsible for the interaction of the virus with host cell receptors. The HA protein on the viral surface is a trimer of HA protein monomers that is enzymatically cleaved to produce amino-terminal HA1 and carboxy-terminal HA2 polypeptides. The globular head consists of only the major part of the HA1 polypeptide, while the stem, which anchors the HA protein into the viral lipid envelope, consists of HA2 and part of HA1. The globular head of the HA protein contains two domains: the receptor-binding domain (RBD), a domain of ~148 amino acid residues that contains the sialic acid binding site, and the residual esterase domain, which is located right at the A smaller region of ~75 amino acid residues below the RBD. The globular head contains several antigenic sites containing immunodominant ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/12A61K39/145C07K14/005C07K14/195
CPCA61K39/12C07K14/005C07K14/195A61K2039/55555C07K2319/00C12N2760/16134C12N2760/16122A61K39/145A61P31/16G01N33/56983G01N2333/11
Inventor J.C.博英顿B.S.格雷厄姆J.R.马斯科拉H.M.亚辛K.S.科贝特S.M.莫因L.王M.凯恩基约
Owner UNITED STATES OF AMERICA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com